Midatech Pharma plc logo
Midatech Pharma plc MTP

Annual report 2024
added 12-13-2025

report update icon

Midatech Pharma plc Gross Profit 2011-2025 | MTP

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Midatech Pharma plc

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - - - - -428 K 1.3 M - 147 K - -

All numbers in GBP currency

Indicator range from annual reports

Maximum Minimum Average
1.3 M -428 K 341 K

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
374 M $ 25.27 -2.43 % $ 1.22 B usaUSA
MorphoSys AG MorphoSys AG
MOR
180 M - 2.43 % $ 254 M germanyGermany
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
-40.6 M $ 4.75 1.61 % $ 788 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
172 K $ 3.26 -3.12 % $ 252 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-32.3 K - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
1.12 M - -15.15 % $ 60.3 M britainBritain
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-523 K - -11.43 % $ 502 K usaUSA
Kamada Ltd. Kamada Ltd.
KMDA
70 M $ 7.03 0.14 % $ 260 M israelIsrael
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.52 B - - $ 40.3 B usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
319 M $ 220.27 4.81 % $ 5 B danmarkDanmark
Albireo Pharma Albireo Pharma
ALBO
39.2 M - -0.23 % $ 916 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
90 K - - $ 7.46 M israelIsrael
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.03 M $ 0.28 -2.28 % $ 609 M israelIsrael
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
177 K $ 3.3 -3.51 % $ 7.94 B australiaAustralia
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 - -1.52 % $ 24.7 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
43.9 B $ 89.78 -0.57 % $ 96.9 B britainBritain
Anika Therapeutics Anika Therapeutics
ANIK
103 M $ 9.57 0.84 % $ 140 M usaUSA
Brickell Biotech Brickell Biotech
BBI
1.82 K - -5.38 % $ 6.06 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
3.22 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
500 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
53.8 M - -7.31 % $ 87 M usaUSA
Benitec Biopharma Benitec Biopharma
BNTC
282 K $ 12.05 -7.06 % $ 496 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
45.8 M $ 2.34 2.59 % $ 14.7 M usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
1 K - -19.68 % $ 18.4 M canadaCanada
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
319 K - -6.81 % $ 3.04 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
-104 K $ 1.29 -3.01 % $ 7.03 M chinaChina
Baudax Bio Baudax Bio
BXRX
-1.24 M - 0.59 % $ 63 K usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
774 M - - - russiaRussia
Catalyst Biosciences Catalyst Biosciences
CBIO
109 M $ 14.01 -8.49 % $ 922 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
61.6 M - -0.88 % $ 598 M usaUSA
Axon Enterprise Axon Enterprise
AXON
1.24 B $ 566.18 -2.56 % $ 42.9 B usaUSA
Cerus Corporation Cerus Corporation
CERS
60.4 M $ 2.16 0.47 % $ 399 M usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
1.07 - - $ 169 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
4.15 M - -16.75 % $ 25.8 M usaUSA
Clovis Oncology Clovis Oncology
CLVS
123 M - -7.23 % $ 13 M usaUSA
Biogen Biogen
BIIB
12.4 B $ 174.42 1.11 % $ 25.4 B usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
5.48 M $ 27.36 -2.09 % $ 1.76 M usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
371 M $ 11.54 0.87 % $ 746 M usaUSA